Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Gross Profit (2016 - 2025)

OptimizeRx (OPRX) has disclosed Gross Profit for 13 consecutive years, with $24.1 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 9.43% to $24.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $73.6 million through Dec 2025, up 23.94% year-over-year, with the annual reading at $73.6 million for FY2025, 23.94% up from the prior year.
  • Gross Profit hit $24.1 million in Q4 2025 for OptimizeRx, up from $17.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $24.1 million in Q4 2025 to a low of $6.1 million in Q1 2021.
  • Historically, Gross Profit has averaged $12.5 million across 5 years, with a median of $12.0 million in 2024.
  • Biggest five-year swings in Gross Profit: dropped 12.96% in 2023 and later surged 64.19% in 2024.
  • Year by year, Gross Profit stood at $12.4 million in 2021, then grew by 0.51% to $12.5 million in 2022, then skyrocketed by 43.25% to $17.8 million in 2023, then increased by 23.44% to $22.0 million in 2024, then grew by 9.43% to $24.1 million in 2025.
  • Business Quant data shows Gross Profit for OPRX at $24.1 million in Q4 2025, $17.5 million in Q3 2025, and $18.6 million in Q2 2025.